Preparation and Evaluation of Lipid-Based Liquid Crystalline Formulation of Fenofibrate

Background: Many drugs have poor water solubility and so the oral delivery of such drugs is usually associated with limitation of low bioavailability and lack of dose proportionality. Lipid-based liquid crystal (LC) systems are excellent potential formulations for increasing dissolution and bioavail...

Full description

Bibliographic Details
Main Authors: Moloud Kazemi, Jaleh Varshosaz, Majid Tabbakhian
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Advanced Biomedical Research
Subjects:
Online Access:http://www.advbiores.net/article.asp?issn=2277-9175;year=2018;volume=7;issue=1;spage=126;epage=126;aulast=Kazemi
id doaj-50b128427ff94c1c8b72ec93d014c37e
record_format Article
spelling doaj-50b128427ff94c1c8b72ec93d014c37e2020-11-25T00:21:44ZengWolters Kluwer Medknow PublicationsAdvanced Biomedical Research2277-91752018-01-017112612610.4103/abr.abr_188_17Preparation and Evaluation of Lipid-Based Liquid Crystalline Formulation of FenofibrateMoloud KazemiJaleh VarshosazMajid TabbakhianBackground: Many drugs have poor water solubility and so the oral delivery of such drugs is usually associated with limitation of low bioavailability and lack of dose proportionality. Lipid-based liquid crystal (LC) systems are excellent potential formulations for increasing dissolution and bioavailability of drugs. The aim of the present study was to formulate lipid-based LC containing fenofibrate (FFB) as a hydrophobic drug. Materials and Methods: The studied variables included lipid and stabilizer concentrations and the type of stabilizer. The LC formation was identified by the polarized optical microscopic method. The effects of variables on formulation characteristics such as particle size, drug release, and rheological behavior were evaluated. Results: The results showed that the prepared formulations had the particle size between 42 and 503 nm. The drug release profiles showed that FFB had the continuous release from the formulations and the highest dissolution efficiency was seen in formulation prepared by 1.5% of glyceryl monostearate and 0.5% of Pluronic F127 as the stabilizer. The change of stabilizer type from colloidal silica to Pluronic F127 increased the drug release, significantly. Conclusions: In the most formulations of FFB LCs, the DE% was more than the pure drug, and therefore, it seems that the liquid crystalline formulations can be effective for enhancing drug release. Furthermore, drug release rate depended on the stabilizer type so that the presence of colloidal silica caused slower drug release compared to Pluronic F127.http://www.advbiores.net/article.asp?issn=2277-9175;year=2018;volume=7;issue=1;spage=126;epage=126;aulast=KazemiBioavailabilityenhanced solubilityfenofibrateliquid crystal
collection DOAJ
language English
format Article
sources DOAJ
author Moloud Kazemi
Jaleh Varshosaz
Majid Tabbakhian
spellingShingle Moloud Kazemi
Jaleh Varshosaz
Majid Tabbakhian
Preparation and Evaluation of Lipid-Based Liquid Crystalline Formulation of Fenofibrate
Advanced Biomedical Research
Bioavailability
enhanced solubility
fenofibrate
liquid crystal
author_facet Moloud Kazemi
Jaleh Varshosaz
Majid Tabbakhian
author_sort Moloud Kazemi
title Preparation and Evaluation of Lipid-Based Liquid Crystalline Formulation of Fenofibrate
title_short Preparation and Evaluation of Lipid-Based Liquid Crystalline Formulation of Fenofibrate
title_full Preparation and Evaluation of Lipid-Based Liquid Crystalline Formulation of Fenofibrate
title_fullStr Preparation and Evaluation of Lipid-Based Liquid Crystalline Formulation of Fenofibrate
title_full_unstemmed Preparation and Evaluation of Lipid-Based Liquid Crystalline Formulation of Fenofibrate
title_sort preparation and evaluation of lipid-based liquid crystalline formulation of fenofibrate
publisher Wolters Kluwer Medknow Publications
series Advanced Biomedical Research
issn 2277-9175
publishDate 2018-01-01
description Background: Many drugs have poor water solubility and so the oral delivery of such drugs is usually associated with limitation of low bioavailability and lack of dose proportionality. Lipid-based liquid crystal (LC) systems are excellent potential formulations for increasing dissolution and bioavailability of drugs. The aim of the present study was to formulate lipid-based LC containing fenofibrate (FFB) as a hydrophobic drug. Materials and Methods: The studied variables included lipid and stabilizer concentrations and the type of stabilizer. The LC formation was identified by the polarized optical microscopic method. The effects of variables on formulation characteristics such as particle size, drug release, and rheological behavior were evaluated. Results: The results showed that the prepared formulations had the particle size between 42 and 503 nm. The drug release profiles showed that FFB had the continuous release from the formulations and the highest dissolution efficiency was seen in formulation prepared by 1.5% of glyceryl monostearate and 0.5% of Pluronic F127 as the stabilizer. The change of stabilizer type from colloidal silica to Pluronic F127 increased the drug release, significantly. Conclusions: In the most formulations of FFB LCs, the DE% was more than the pure drug, and therefore, it seems that the liquid crystalline formulations can be effective for enhancing drug release. Furthermore, drug release rate depended on the stabilizer type so that the presence of colloidal silica caused slower drug release compared to Pluronic F127.
topic Bioavailability
enhanced solubility
fenofibrate
liquid crystal
url http://www.advbiores.net/article.asp?issn=2277-9175;year=2018;volume=7;issue=1;spage=126;epage=126;aulast=Kazemi
work_keys_str_mv AT moloudkazemi preparationandevaluationoflipidbasedliquidcrystallineformulationoffenofibrate
AT jalehvarshosaz preparationandevaluationoflipidbasedliquidcrystallineformulationoffenofibrate
AT majidtabbakhian preparationandevaluationoflipidbasedliquidcrystallineformulationoffenofibrate
_version_ 1725361260997902336